Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:citation |
peer-reviewed publications
|
| gptkbp:commercialUse |
gptkb:Quanterix
|
| gptkbp:competitor |
gptkb:ELISA
gptkb:MSD_(Meso_Scale_Discovery) |
| gptkbp:detects |
gptkb:tau_protein
gptkb:amyloid_beta gptkb:SARS-CoV-2_antibodies gptkb:SARS-CoV-2_antigens gptkb:neurofilament_light_chain_(NfL) gptkb:phosphorylated_tau cytokines nucleic acids proteins cardiac biomarkers infectious disease markers autoimmune disease markers cancer biomarkers inflammatory markers |
| gptkbp:developedBy |
gptkb:Quanterix
|
| gptkbp:enables |
multiplexing
early disease detection single-molecule detection digital immunoassay detection of attomolar concentrations detection of femtomolar concentrations high sensitivity assays longitudinal biomarker monitoring low sample volume analysis |
| https://www.w3.org/2000/01/rdf-schema#label |
Simoa technology
|
| gptkbp:launched |
2010s
|
| gptkbp:platforms |
gptkb:SP-X_Imaging_and_Analysis_System
gptkb:Simoa_HD-1_Analyzer gptkb:Simoa_HD-X_Analyzer gptkb:Simoa_SR-X_Analyzer |
| gptkbp:standsFor |
gptkb:Single_Molecule_Array
|
| gptkbp:usedBy |
academic researchers
clinical laboratories pharmaceutical companies biotech companies |
| gptkbp:usedFor |
biomarker quantification
ultrasensitive protein detection |
| gptkbp:usedIn |
life sciences research
clinical diagnostics |
| gptkbp:uses |
digital counting
enzyme-labeled antibodies fluorescent detection microwell arrays paramagnetic beads |
| gptkbp:bfsParent |
gptkb:Quanterix
|
| gptkbp:bfsLayer |
6
|